2019 International Mental Health Research Symposium

Friday, November 1, 2019, 9:00 am EDT
Altha Stewart Speaks at last years Mental Health Research Symposium

Join us for a special keynote talk titled "New Thoughts About Mental Illness: Implications for Discovery & Treatment" by William T. Carpenter, Jr., M.D. along with updates on the leading research discoveries across brain and behavior disorders by the Foundation’s 2019 Outstanding Achievement Prizewinners.

Friday, November 1, 2019
9:00AM - 4:30PM


Kaufman Music Center
129 West 67th St. (btw Broadway and Amsterdam)
New York, NY 10023

Full day program is complimentary. Please consider helping support these research presentations by donating to this event.

Join us after the Symposium for the 2019 BBRF International Awards Dinner.


Registration: 8:30 am
Morning Session: 9:00 am-12:10 pm

Early Life Determinants of Schizophrenia & Other Psychiatric Disorders
Alan S. Brown, M.D., M.P.H.
Columbia University Irving Medical Center / New York State Psychiatric Institute

Thalamo-cortical Interactions in Cognition
Christoph Kellendonk, Ph.D.
Columbia University Irving Medical Center / New York State Psychiatric Institute

Preventing Schizophrenia – ‘Thinking the Unthinkable’
John J. McGrath, M.D., Ph.D.
The University of Queensland / Queensland Centre for Mental Health Research

Decision Making & Neuropsychiatry: What Can We Learn from the Decisions We Make?
James P. Kesby, Ph.D.
The University of Queensland

The Shape of Discovery: Ketamine for Treatment Resistant Depression
Dennis S. Charney, M.D.
Icahn School of Medicine at Mount Sinai

Break: 12:10 pm-1:20 pm
Afternoon Session: 1:20 pm-4:30 pm

Keynote Presentation

New Thoughts About Mental Illness: Implications for Discovery & Treatment
William T. Carpenter, Jr., M.D.
Professor of Psychiatry & Pharmacology
Maryland Psychiatric Research Center
University of Maryland School of Medicine

Resilient Brains: Adaptive Brain Mechanisms in Bipolar Disorder
Sophia Frangou, M.D., Ph.D., F.R.C.Psych
Icahn School of Medicine at Mount Sinai

Ketamine: Imagining New Ways to Treat Depression
John H. Krystal, M.D.
Yale University

Developmental Psychopathology & Stigma Reduction: A Synthesis
Stephen P. Hinshaw, Ph.D.
University of California, Berkeley / University of California, San Francisco

Harnessing Hippocampal Neurogenesis to Improve Cognition and Mood
René Hen, Ph.D.
Columbia University / New York State Psychiatric Institute

The order of the presentations is subject to change.

Thank you to our Sponsors:
sunovion-logo-small.jpg     allergan-logo.jpg

Moderated by 
Robert M.A. Hirschfeld, M.D.
Weill Cornell Medical College, Cornell University

DeWitt Wallace Senior Scholar

Professor of Psychiatry

Scientific Council Member (Founding Member)

2003 Falcone Prize for Outstanding Achievement in Affective Disorders Research (Colvin Prize)

2002 Distinguished Investigator Grant

Dr. Hirschfeld’s research has significantly contributed to understanding the classifications of depression and bipolar disorders; their clinical course, relationship to personality and personality disorders and treatment with medication and psychotherapy. He and his colleagues developed the Mood Disorder Questionnaire, the most widely used screening instrument for bipolar disorder.

Dr. Hirschfeld chaired the original and revised versions of the American Psychiatric Association’s working group to develop practice guidelines for treatment of patients with bipolar disorder. He was Chief of the Mood, Anxiety and Personality Disorders Research Branch and Clinical Director of the Depression Awareness, Recognition and Treatment (D/ART) Program of the NIMH.